Literature DB >> 26033161

What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy.

Eric H Kossoff1, Nabil Al-Macki2, Mackenzie C Cervenka1, Heung D Kim3, Jianxiang Liao4, Katherine Megaw5, Janak K Nathan6, Ximena Raimann7, Rocio Rivera8, Adelheid Wiemer-Kruel9, Emma Williams10, Beth A Zupec-Kania11.   

Abstract

Despite the increasing use of dietary therapies for children and adults with refractory epilepsy, the availability of these treatments in developing countries with limited resources remains suboptimal. One possible contributory factor may be the costs. There is often reported a significant perceived need for a large ketogenic diet team, supplements, laboratory studies, and follow-up visits to provide this treatment. The 2009 Epilepsia Consensus Statement described ideal requirements for a ketogenic diet center, but in some situations this is not feasible. As a result, the International League Against Epilepsy (ILAE) Task Force on Dietary Therapy was asked to convene and provide practical, cost-effective recommendations for new ketogenic diet centers in resource-limited regions of the world. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  Diet; Epilepsy; Global; Ketogenic; Minimum; Resources

Mesh:

Year:  2015        PMID: 26033161     DOI: 10.1111/epi.13039

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

Review 1.  Metabolism and epilepsy: Ketogenic diets as a homeostatic link.

Authors:  Susan A Masino; Jong M Rho
Journal:  Brain Res       Date:  2018-06-06       Impact factor: 3.252

Review 2.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

Review 3.  Global Health and Epilepsy: Update and Future Directions.

Authors:  Mary C Spiciarich; Jane R von Gaudecker; Laura Jurasek; Dave F Clarke; Jorge Burneo; Jorge Vidaurre
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-01       Impact factor: 5.081

Review 4.  Progress towards the 2030 sustainable development goals: direct and indirect impacts on neurological disorders.

Authors:  Farrah J Mateen
Journal:  J Neurol       Date:  2022-05-18       Impact factor: 6.682

5.  Ketogenic Diets for Adults With Highly Refractory Epilepsy.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Epilepsy Curr       Date:  2017 Nov-Dec       Impact factor: 7.500

Review 6.  The role for ketogenic diets in epilepsy and status epilepticus in adults.

Authors:  Tanya J Williams; Mackenzie C Cervenka
Journal:  Clin Neurophysiol Pract       Date:  2017-07-01

7.  Implementation of ketogenic diet in children with drug-resistant epilepsy in a medium resources setting: Egyptian experience.

Authors:  Mary Gerges; Laila Selim; Marian Girgis; Amr El Ghannam; Hadeer Abdelghaffar; Ahmed El-Ayadi
Journal:  Epilepsy Behav Case Rep       Date:  2018-11-23

8.  Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.

Authors:  Kirsty J Martin-McGill; Anthony G Marson; Catrin Tudur Smith; Michael D Jenkinson
Journal:  Pilot Feasibility Stud       Date:  2017-11-28

9.  Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations.

Authors:  Eric H Kossoff; Zahava Turner; Jamie Adams; Stacey K Bessone; Jennifer Avallone; Tanya J W McDonald; Luisa Diaz-Arias; Bobbie J Barron; Diane Vizthum; Mackenzie C Cervenka
Journal:  Epilepsy Behav       Date:  2020-05-25       Impact factor: 2.937

10.  Ketogenic diet in Zambia: Managing drug-resistant epilepsy in a low and middle income country.

Authors:  Kafula Lisa Nkole; Nfwama Kawatu; Archana A Patel; Chimbizyani Kanyinji; Theresa Njobvu; James Chipeta; John Musuku; Ornella Ciccone; Stacey Tarrant; Ann Marie Bergin
Journal:  Epilepsy Behav Rep       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.